Beech Tree Labs and its predecessor, Milkhaus Laboratory, have conducted a number of controlled clinical trials that individually and collectively demonstrate the promise of the RMS approach to therapy. Disorders targeted in the successful trials include:
Multiple sclerosis
Benign Prostatic Hyperplasia
Urinary Incontinence
Chronic Fatigue Syndrome
Chronic Obstructive Pulmonary Disease
Herpesvirus Infection
Chronic Bronchitis
Cancer (FDA and USDA)
Myositis (USDA)
Cardiomyopathy
Validation of this approach is also found in the publication of peer-reviewed papers addressing the mechanism of action and clinical efficacy of Beech Tree’s therapeutic agents.